Work

Pos1062 Therapeutic Potential of Imvotamab, a Cd20-targeted Bispecific Igm T Cell Engager, for the Treatment of Refractory Autoimmune Disease Patients

Year: 2024

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2024-eular.3799

Authors: R. Domingo-Gonzalez, I. Baribaud, M. Oyasu, K. Hart, K. Burns, S. Pandey, M. Leabman, G. Hernandez, A. Candia, S. Carroll, R. Kunder, B. Keyt, M. Kotturi, C. Brodmerkel, M.B. Harler

Institution: IGM Biosciences (United States)

Language: English

Topic: Systemic Lupus Erythematosus Research

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4399482170

Cites:

Cited by: 10

Related to: 10